세계의 수면 소프트웨어 시장 예측(-2030년) : 유형별, 오퍼링별, 기능별, 적응증별, 도입 모델별, 최종사용자별, 지역별

The global Sleep Software market is projected to reach USD 1,569.2 Million by 2030 from USD 878.9 million in 2024, at a CAGR of 10.1% during the forecast period. The growth in the sleep software market is driven by the shift towards preventive health since individuals and health systems are putting more emphasis on proactive wellness approaches rather than reacting to treatments. Sleep software can play a major role in such a shift by allowing users to track their sleep, spot early sleep issues, and develop healthier habits for long-term wellness. As awareness grows about the link between sleep quality and chronic conditions such as obesity, heart disease, and mental health disorders, consumers are increasingly adopting tools that help address potential issues before they become serious.

"The mobile applications segment is expected to register the fastest growth during the forecast period, by offering"

The Sleep Software market, by offering, is segmented into platforms and applications. The mobile applications segment is expected to grow the fastest during the forecast period due to the rapid growth of mobile-based applications in the sleep software market, which is driven by rising awareness of sleep health, increasing sleep disorders, and advancements in technology. Sleep apps such as Sleep Cycle, Calm, and Headspace offer features such as tracking, relaxation, and integration with wearables. Demand is further increased by stressful lives and health trends, with products such as Moshi for kids and CBT-I Coach for sleeplessness. These apps are now widely available and crucial for improved sleep management due to their affordable models and pandemic-driven mental health focus.

"Cloud-based segment dominated the sleep software market, by deployment model."

By deployment model, the Sleep Software market is divided into on-premise models and cloud-based models. In 2023, cloud-based models, by deployment model, held a large share of the Sleep Software market. Owing to its scalability, cost efficiency, and accessibility. Cloud solutions enable easy expansion without significant infrastructure costs while providing users with real-time data synchronization across devices. The cloud platforms offer robust data security and seamless updates that continue to allow access to the latest feature upgrades. Integration capabilities with other health platforms and global reach provide an added strength in terms of dominance in the market share.

"Asia Pacific is expected to register the fastest market growth during the forecast period."

The Sleep Software market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The sleep software market in the Asia Pacific region is being driven by growing awareness of sleep's critical role in health and productivity, with rising consumer focus on addressing issues like insomnia and sleep apnea, exacerbated by urbanization and high-stress lifestyles. The growing middle class and increasing disposable incomes in key markets such as India, China, and Indonesia fuel demand for innovative sleep solutions, including apps and wearable integrations, as consumers focus on wellness and invest in health-focused technologies.

The break-down of primary participants is as mentioned below:

• By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
• By Designation - Directors: 30%, Manager: 34%, and Others: 36%
• By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3% and Middle East & Africa: 2%

List of Companies Profiled in the Report

1. Koninklijke Philips N.V. (Netherlands)

2. Cadwell Industries Inc. (US)

3. COMPUMEDICS LIMITED (Australia)

4. Neurovirtual. (US)

5. NIHON KOHDEN CORPORATION (Japan)

6. Nox Medical (Iceland)

7. Natus Medical Incorporated (ARCHIMED) (US)

8. RXNT (US)

9. Resmed (US)

10. Cleveland Medical Devices Inc. (US)

11. SOMNOmedics AG (Germany)

12. CIDELEC (France)

13. Calm (US)

14. Sleep Cycle (Sweden)

15. Headspace Inc. (US)

16. Lowenstein Medical SE & Co. KG (Germany)

17. CamNtech Ltd (United Kingdom)

18. Fisher & Paykel Healthcare Limited. (New Zealand)

19. BioSerenity (France)

20. VYAIRE MEDICAL INC (US)

21. Inspire Medical Systems, Inc. (US)

22. HoneyNaps (South Korea)

23. Sleep Reset (US)

24. SleepImage. (US)

25. BigHealth (US)

26. Bodymatter, Inc. (US)

27. Neybox Digital Ltd. (US)

28. Consumer Sleep Solutions LLC. (US)

Research Coverage:

The report analyzes the sleep software market and aims to estimate the market size and future growth potential of various market segments based on type, offering, function, indication, deployment model, end user, and region. The report also analyses factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges for stakeholders in the market. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total sleep software market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of key drivers (growing incidence of sleep disorders, increasing adoption of telehealth and mhealth, increasing emphasis on corporate wellness programs, growing awareness regarding sleep apnea and wellness improvement, favorable reimbursement and financial aid for sleep apnea devices and therapies), restraints (use of alternative therapies and medications for sleep disorders, data security and privacy concerns, resistance from tradition healthcare providers), opportunities (adoption of advanced technologies, integration with wearable devices, personalized sleep solutions, mental health and wellness integration), challenges (lack of clinical validation for many solutions, regulatory compliance complexities, growing concerns about data privacy and security.) are factors contributing the growth of the sleep software market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the sleep software market.
• Market Development: Comprehensive information on the lucrative emerging markets, type, offering, function, indications, deployment model, end user, and region.
• Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, and investments in the sleep software market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global sleep software market such as Koninklijke Philips N.V. (Netherlands), Resmed (US), Calm (US), Headspace Inc. (US), Inspire Medical Systems, Inc. (US).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key industry insights
• 2.2 MARKET ESTIMATION METHODOLOGY
• 2.3 MARKET SIZE ESTIMATION
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
  • 2.5.1 MARKET SIZING ASSUMPTIONS
  • 2.5.2 OVERALL STUDY ASSUMPTIONS
• 2.6 RISK ASSESSMENT
• 2.7 RESEARCH LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.7.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 SLEEP SOFTWARE MARKET OVERVIEW
• 4.2 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY END USER & REGION
• 4.3 SLEEP SOFTWARE MARKET: GEOGRAPHIC MIX
• 4.4 SLEEP SOFTWARE MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Expansion of telehealth and remote patient monitoring
    • 5.2.1.2 Vast population of undiagnosed sleep apnea patients
    • 5.2.1.3 Growing awareness regarding sleep apnea and wellness improvement
    • 5.2.1.4 Favorable reimbursement and financial aid for sleep apnea devices and therapies
    • 5.2.1.5 Increasing emphasis on corporate wellness programs
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Data privacy and security concerns
    • 5.2.2.2 Use of alternative therapies and medications for sleep disorders
    • 5.2.2.3 Resistance from traditional healthcare providers
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Development of mHealth tools
    • 5.2.3.2 Rising potential of AI & ML in sleep medicine
    • 5.2.3.3 Rising demand for smart wearables
    • 5.2.3.4 Increasing focus on mental health and wellbeing
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Lack of clinical validation of sleep apps
    • 5.2.4.2 Strategic challenges in monetizing sleep apps
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.4 INDUSTRY TRENDS
  • 5.4.1 VALUE-BASED CARE MODELS
  • 5.4.2 CLOUD-BASED SOLUTIONS
  • 5.4.3 IOT AND WEARABLES
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 SUPPLY CHAIN ANALYSIS
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 Artificial intelligence & machine learning
    • 5.7.1.2 Internet of things (IoT)
    • 5.7.1.3 Mobile applications
    • 5.7.1.4 Biosensors and wearable technology
    • 5.7.1.5 Gamification technology
    • 5.7.1.6 Voice assistants
  • 5.7.2 COMPLEMENTARY TECHNOLOGIES
    • 5.7.2.1 Smart home automation
    • 5.7.2.2 Telemedicine platforms
    • 5.7.2.3 Data analysis and visualization tools
    • 5.7.2.4 EHR integration
    • 5.7.2.5 Cloud computing
  • 5.7.3 ADJACENT TECHNOLOGIES
    • 5.7.3.1 Fitness trackers
    • 5.7.3.2 Respiratory monitoring devices
    • 5.7.3.3 Augmented reality (AR) & virtual reality (VR)
• 5.8 REGULATORY ANALYSIS
  • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8.2 REGULATORY SCENARIO
    • 5.8.2.1 North America
    • 5.8.2.2 Europe
    • 5.8.2.3 Asia Pacific
    • 5.8.2.4 Middle East & Africa
    • 5.8.2.5 Latin America
• 5.9 PRICING ANALYSIS
  • 5.9.1 AVERAGE SELLING PRICE OF SLEEP APPS, BY KEY PLAYER (2023)
  • 5.9.2 AVERAGE SELLING PRICE OF SLEEP APPS, BY REGION (2023)
• 5.10 PORTER'S FIVE FORCES ANALYSIS
  • 5.10.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10.2 BARGAINING POWER OF BUYERS
  • 5.10.3 THREAT OF SUBSTITUTES
  • 5.10.4 THREAT OF NEW ENTRANTS
  • 5.10.5 BARGAINING POWER OF SUPPLIERS
• 5.11 PATENT ANALYSIS
  • 5.11.1 PATENT PUBLICATION TRENDS
  • 5.11.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR SLEEP SOFTWARE
  • 5.11.3 MAJOR PATENTS IN SLEEP SOFTWARE MARKET
• 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.12.2 KEY BUYING CRITERIA
• 5.13 END-USER ANALYSIS
  • 5.13.1 UNMET NEEDS
  • 5.13.2 END-USER EXPECTATIONS
• 5.14 KEY CONFERENCES & EVENTS, 2025-2026
• 5.15 CASE STUDY ANALYSIS
  • 5.15.1 CASE STUDY 1: TRANSFORMING SLEEP STUDY AT ST. LUKE'S SLEEP MEDICINE INSTITUTE
  • 5.15.2 CASE STUDY 2: GRANGER MEDICAL CLINIC'S PATH TO EFFICIENT HEALTHCARE OPERATIONS
• 5.16 INVESTMENT & FUNDING SCENARIO
• 5.17 BUSINESS MODEL ANALYSIS
• 5.18 IMPACT OF AI/GEN AI ON SLEEP SOFTWARE MARKET
  • 5.18.1 KEY USE CASES
  • 5.18.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
    • 5.18.2.1 Case study 1: Leveraging AI to drive improved patient adherence and operational efficiency at Aeroflow Sleep
    • 5.18.2.2 Case study 2: Optimizing sleep lab workflow and enhancing patient care with EnsoSleep AI at Northwell Health
  • 5.18.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
    • 5.18.3.1 Remote patient monitoring market
    • 5.18.3.2 Digital health market
    • 5.18.3.3 Telehealth and telemedicine market
    • 5.18.3.4 mHealth market
  • 5.18.4 USER READINESS AND IMPACT ASSESSMENT
    • 5.18.4.1 User readiness
      • 5.18.4.1.1 User A: Individual users
      • 5.18.4.1.2 User B: Healthcare providers
    • 5.18.4.2 Impact assessment
      • 5.18.4.2.1 User A: Individual users
      • 5.18.4.2.2 User B: Healthcare providers

6 SLEEP SOFTWARE MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 INTEGRATED SOFTWARE
  • 6.2.1 NEED FOR INTEGRATED SOFTWARE WITHIN BROADER HEALTH AND WELLNESS ECOSYSTEMS TO BOLSTER GROWTH
• 6.3 STANDALONE SOFTWARE
  • 6.3.1 RISING TREND TOWARD MOBILE HEALTH APPLICATIONS TO INTENSIFY GROWTH

7 SLEEP SOFTWARE MARKET, BY OFFERING

• 7.1 INTRODUCTION
• 7.2 PLATFORMS
  • 7.2.1 GROWING ADOPTION OF CONNECTED HEALTH TECHNOLOGIES TO BOOST MARKET
• 7.3 APPLICATIONS
  • 7.3.1 MOBILE APPLICATIONS
    • 7.3.1.1 Increasing penetration of smartphones and consumer demand for on-the-go health monitoring tools to aid growth
  • 7.3.2 DESKTOP APPLICATIONS
    • 7.3.2.1 Need for advanced solutions to address sleep issues and improve sleep quality to expedite growth

8 SLEEP SOFTWARE MARKET, BY FUNCTION

• 8.1 INTRODUCTION
• 8.2 SLEEP TRACKING
  • 8.2.1 RISING HEALTH AWARENESS ABOUT IMPORTANCE OF SLEEP TO FACILITATE GROWTH
• 8.3 SLEEP IMPROVEMENT
  • 8.3.1 INCREASING PREFERENCE FOR NON-INVASIVE SOLUTIONS FOR SLEEP IMPROVEMENT TO FAVOR GROWTH
• 8.4 SLEEP ANALYSIS
  • 8.4.1 GROWING INTEGRATION OF SLEEP ANALYSIS TOOLS INTO WEARABLES TO FUEL MARKET
• 8.5 SLEEP DISORDER MANAGEMENT
  • 8.5.1 INCREASING RESEARCH ON SLEEP DISORDER DIAGNOSTICS TO SUPPORT GROWTH

9 SLEEP SOFTWARE MARKET, BY INDICATION

• 9.1 INTRODUCTION
• 9.2 INSOMNIA
  • 9.2.1 RISING MENTAL HEALTH ISSUES AND DEMAND FOR NON-PHARMACOLOGICAL TREATMENTS TO AID GROWTH
• 9.3 SLEEP APNEA
  • 9.3.1 GROWING PATIENT SHIFT TO DIGITAL SOLUTIONS TO BOOST MARKET
• 9.4 GENERAL SLEEP IMPROVEMENT
  • 9.4.1 RISE IN HEALTH CONSCIOUSNESS AMONG CONSUMERS TO AUGMENT GROWTH
• 9.5 OTHER INDICATIONS

10 SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL

• 10.1 INTRODUCTION
• 10.2 ON-PREMISE MODELS
  • 10.2.1 NEED FOR ENHANCED DATA CONTROL, SECURITY, AND COMPLIANCE TO PROMOTE GROWTH
• 10.3 CLOUD-BASED MODELS
  • 10.3.1 GROWING ADOPTION OF REMOTE PATIENT MONITORING SYSTEMS TO DRIVE MARKET

11 SLEEP SOFTWARE MARKET, BY END USER

• 11.1 INTRODUCTION
• 11.2 INDIVIDUAL USERS
  • 11.2.1 GROWING AWARENESS OF SLEEP HEALTH AND ADOPTION OF WEARABLE TRACKERS TO PROPEL MARKET
• 11.3 HEALTHCARE PROVIDERS
  • 11.3.1 RISING TECHNOLOGICAL ADVANCEMENTS IN SLEEP SOFTWARE TO DRIVE MARKET
• 11.4 OTHER END USERS

12 SLEEP SOFTWARE MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 12.2.2 US
    • 12.2.2.1 Increasing investments due to reduced workplace productivity and decreased quality of life to drive market
  • 12.2.3 CANADA
    • 12.2.3.1 Government investments and increasing awareness to drive market
• 12.3 EUROPE
  • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 12.3.2 GERMANY
    • 12.3.2.1 Growing need for effective diagnostic and treatment solutions to drive market
  • 12.3.3 UK
    • 12.3.3.1 Rising interest in sleep management apps to favor market
  • 12.3.4 FRANCE
    • 12.3.4.1 Rising awareness and supportive government initiatives to fuel market growth
  • 12.3.5 ITALY
    • 12.3.5.1 Growing insomnia prevalence in Italy to propel market
  • 12.3.6 SPAIN
    • 12.3.6.1 Increasing incidence of sleep problems in younger populations to drive demand
  • 12.3.7 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 12.4.2 CHINA
    • 12.4.2.1 Rising sleep disorder prevalence to drive market
  • 12.4.3 INDIA
    • 12.4.3.1 Collaborative efforts with other countries to support market growth
  • 12.4.4 JAPAN
    • 12.4.4.1 Need for digital solutions and government initiatives to drive market
  • 12.4.5 REST OF ASIA PACIFIC
• 12.5 LATIN AMERICA
  • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 12.5.2 BRAZIL
    • 12.5.2.1 Rising cases of sleep disorders among older adults to drive market
  • 12.5.3 MEXICO
    • 12.5.3.1 Socioeconomic factors and environmental stressors to support market growth
  • 12.5.4 REST OF LATIN AMERICA
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 12.6.2 GCC COUNTRIES
    • 12.6.2.1 Rising obesity rate to drive demand for sleep disorder treatment solutions in GCC countries
  • 12.6.3 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

• 13.1 INTRODUCTION
• 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP SOFTWARE MARKET
• 13.3 REVENUE ANALYSIS, 2019-2023
• 13.4 MARKET SHARE ANALYSIS, 2023
• 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 13.5.1 STARS
  • 13.5.2 EMERGING LEADERS
  • 13.5.3 PERVASIVE PLAYERS
  • 13.5.4 PARTICIPANTS
  • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 13.5.5.1 Company footprint
    • 13.5.5.2 Region footprint
    • 13.5.5.3 Type footprint
    • 13.5.5.4 Offering footprint
    • 13.5.5.5 Function footprint
    • 13.5.5.6 Indication footprint
    • 13.5.5.7 Deployment footprint
    • 13.5.5.8 End-user footprint
• 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 13.6.1 PROGRESSIVE COMPANIES
  • 13.6.2 RESPONSIVE COMPANIES
  • 13.6.3 DYNAMIC COMPANIES
  • 13.6.4 STARTING BLOCKS
  • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 13.6.5.1 Detailed list of key startups/SMEs
    • 13.6.5.2 Competitive benchmarking of key startups/SMEs
• 13.7 COMPANY VALUATION & FINANCIAL METRICS
• 13.8 BRAND/SOFTWARE COMPARISON
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 PRODUCT LAUNCHES & ENHANCEMENTS
  • 13.9.2 DEALS
  • 13.9.3 EXPANSIONS
  • 13.9.4 OTHER DEVELOPMENTS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
  • 14.1.1 CALM
    • 14.1.1.1 Business overview
    • 14.1.1.2 Solutions offered
    • 14.1.1.3 Recent developments
      • 14.1.1.3.1 Deals
    • 14.1.1.4 MnM view
      • 14.1.1.4.1 Right to win
      • 14.1.1.4.2 Strategic choices
      • 14.1.1.4.3 Weaknesses & competitive threats
  • 14.1.2 HEADSPACE INC.
    • 14.1.2.1 Business overview
    • 14.1.2.2 Solutions offered
    • 14.1.2.3 Recent developments
      • 14.1.2.3.1 Product launches
      • 14.1.2.3.2 Deals
      • 14.1.2.3.3 Other developments
    • 14.1.2.4 MnM view
      • 14.1.2.4.1 Right to win
      • 14.1.2.4.2 Strategic choices
      • 14.1.2.4.3 Weaknesses & competitive threats
  • 14.1.3 RESMED
    • 14.1.3.1 Business overview
    • 14.1.3.2 Solutions offered
    • 14.1.3.3 Recent developments
      • 14.1.3.3.1 Product enhancements
      • 14.1.3.3.2 Deals
      • 14.1.3.3.3 Expansions
    • 14.1.3.4 MnM view
      • 14.1.3.4.1 Right to win
      • 14.1.3.4.2 Strategic choices
      • 14.1.3.4.3 Weaknesses & competitive threats
  • 14.1.4 KONINKLIJKE PHILIPS N.V.
    • 14.1.4.1 Business overview
    • 14.1.4.2 Solutions offered
    • 14.1.4.3 MnM view
      • 14.1.4.3.1 Right to win
      • 14.1.4.3.2 Strategic choices
      • 14.1.4.3.3 Weaknesses & competitive threats
  • 14.1.5 INSPIRE MEDICAL SYSTEMS, INC.
    • 14.1.5.1 Business overview
    • 14.1.5.2 Solutions offered
    • 14.1.5.3 MnM view
      • 14.1.5.3.1 Right to win
      • 14.1.5.3.2 Strategic choices
      • 14.1.5.3.3 Weaknesses & competitive threats
  • 14.1.6 CADWELL INDUSTRIES INC.
    • 14.1.6.1 Business overview
    • 14.1.6.2 Solutions offered
    • 14.1.6.3 Recent developments
      • 14.1.6.3.1 Deals
  • 14.1.7 COMPUMEDICS LIMITED
    • 14.1.7.1 Business overview
    • 14.1.7.2 Solutions offered
  • 14.1.8 NEUROVIRTUAL
    • 14.1.8.1 Business overview
    • 14.1.8.2 Solutions offered
    • 14.1.8.3 Recent developments
      • 14.1.8.3.1 Expansions
  • 14.1.9 NIHON KOHDEN CORPORATION
    • 14.1.9.1 Business overview
    • 14.1.9.2 Solutions offered
    • 14.1.9.3 Recent developments
      • 14.1.9.3.1 Deals
      • 14.1.9.3.2 Expansions
  • 14.1.10 NOX MEDICAL
    • 14.1.10.1 Business overview
    • 14.1.10.2 Solutions offered
    • 14.1.10.3 Recent developments
      • 14.1.10.3.1 Product launches & enhancements
  • 14.1.11 NATUS MEDICAL INCORPORATED
    • 14.1.11.1 Business overview
    • 14.1.11.2 Solutions offered
    • 14.1.11.3 Recent developments
      • 14.1.11.3.1 Deals
  • 14.1.12 RXNT
    • 14.1.12.1 Business overview
    • 14.1.12.2 Solutions offered
    • 14.1.12.3 Recent developments
      • 14.1.12.3.1 Product launches
  • 14.1.13 CLEVELAND MEDICAL DEVICES INC.
    • 14.1.13.1 Business overview
    • 14.1.13.2 Solutions offered
    • 14.1.13.3 Recent developments
      • 14.1.13.3.1 Product enhancements
  • 14.1.14 SOMNOMEDICS AG
    • 14.1.14.1 Business overview
    • 14.1.14.2 Solutions offered
    • 14.1.14.3 Recent developments
      • 14.1.14.3.1 Deals
  • 14.1.15 CIDELEC
    • 14.1.15.1 Business overview
    • 14.1.15.2 Solutions offered
  • 14.1.16 SLEEP CYCLE
    • 14.1.16.1 Business overview
    • 14.1.16.2 Solutions offered
    • 14.1.16.3 Recent developments
      • 14.1.16.3.1 Product launches
      • 14.1.16.3.2 Deals
  • 14.1.17 LOWENSTEIN MEDICAL SE & CO. KG
    • 14.1.17.1 Business overview
    • 14.1.17.2 Solutions offered
  • 14.1.18 CAMNTECH LTD.
    • 14.1.18.1 Business overview
    • 14.1.18.2 Solutions offered
    • 14.1.18.3 Recent developments
      • 14.1.18.3.1 Product launches
  • 14.1.19 FISHER & PAYKEL HEALTHCARE LIMITED
    • 14.1.19.1 Business overview
    • 14.1.19.2 Solutions offered
    • 14.1.19.3 Recent developments
      • 14.1.19.3.1 Product launches
      • 14.1.19.3.2 Expansions
  • 14.1.20 BIOSERENITY
    • 14.1.20.1 Business overview
    • 14.1.20.2 Solutions offered
    • 14.1.20.3 Recent developments
      • 14.1.20.3.1 Other developments
  • 14.1.21 VYAIRE MEDICAL, INC.
    • 14.1.21.1 Business overview
    • 14.1.21.2 Solutions offered
• 14.2 OTHER PLAYERS
  • 14.2.1 HONEYNAPS
  • 14.2.2 SLEEPIMAGE
  • 14.2.3 SLEEP RESET
  • 14.2.4 BIGHEALTH
  • 14.2.5 BODYMATTER, INC.
  • 14.2.6 NEYBOX DIGITAL LTD.
  • 14.2.7 CONSUMER SLEEP SOLUTIONS LLC

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS